Valeant Pharmaceuticals Intl Inc (VRX) Stock Rating Reaffirmed by RBC Capital
's stock had its "hold" rating reissued by research analysts at RBC Capital in a note issued to investors on Thursday. A number of hedge funds have recently added to or reduced their stakes in VRX.
from Biotech News
0 Comments